RxDoctor Payments Data

Yana Roddenberry, DPM

Foot & Ankle Surgery · Miami, FLNPI 1952644957

Payments from drug & device makers

$990in general payments, 2019–2025

Across 27 payments — averaging $36.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$625
  • Smith+Nephew$150
  • ETS Wound Care LLC$130
  • Kerecis Limited$43
  • Zyla Life Sciences, Inc.$23
  • AbbVie$18

What the payments were for

  • Food & beverage$990100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.16$625
Smith+Nephew5$150
ETS Wound Care LLC1$130
Kerecis Limited2$43
Zyla Life Sciences, Inc.2$23
AbbVie1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$990 in reported general payments places this provider in the 25th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$196,674
Medicare patients
205
Services billed
886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate13$678
Ciclopirox14$555
Ammonium Lactate25$431
Doxycycline Hyclate16$232
Mupirocin21$140
Ketoconazole11$115
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$67

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →